© Genesis Research Services, 2023
Menu
And just like that, December has arrived. Reflecting on the past 11 months, we’re proud to share some significant highlights:
As the year comes to a close, please note that our office will be closed from Friday, 22nd December, and will reopen on Monday, 8th January. During this time, our emergency phone will remain active for our trial participants. For any non-urgent matters, we kindly request your patience until we return to the office. Thank you.
We wish you all a wonderful holiday time and a Happy New Year!
Do you suffer from migraine episodes? We are looking for volunteers for a study testing a new medication for migraine prevention. The drug aims to block inflammation, pain transmission, and decrease artery dilation. It is an oral drug that quickly dissolves on the tongue and is taken every second day for 24 weeks during the study.
View our trials page for more information.
Do you suffer from depressive symptoms? We are currently recruiting participants for a new clinical trial for people living with Depression / Major Depressive Disorder. The trial involves an investigational drug that aims to improve the cognitive symptoms associated with depression, such as memory loss, and difficulty thinking and making decisions.
View our trials page for more information.
We are recruiting participants for a clinical trial for people living with chronic low back and/or leg pain. This trial involves the use of an investigational spinal cord stimulator (SCS).
If a trial of the temporary investigational device provides effective pain relief, you may be eligible for the permanent implant of the investigational device. You will attend our clinic regularly to see our doctors and clinical team for your follow-up care.
View our trials page for more information.
Don’t see the study you are looking for?
We are always looking for participants for new clinical research here in Newcastle.
We regularly conduct clinical trials involving new treatments for a range of pain conditions, such as low back pain, osteoarthritis pain, neuropathic pain, and others. We also conduct psychiatry studies, vaccine studies, and more.
To register your interest for future studies, visit our trials page.
A warm welcome to the delightful Melinda Huber. Mel H recently joined the team as our financial administrator. She brings a vibrant personality, an extensive banking and financial background, and the skills to support a high level of quality customer service. Her role includes maintaining the integrity of our accounting and financial reporting.
With a keen eye for detail and a strategic mindset, Mel navigates the complexities of financial management to drive sustainable growth and success for our organisation.
Introducing you to our wonderful new clinical trial coordinator, Melissa Young. Mel Y has worked for over 17 years as a CTC in the fields of gastroenterology, hepatology, and infectious diseases. Her experience extends to numerous NSW Health roles, including 23 years as an Endorsed Enrolled nurse in gastroenterology / hepatology, and a project officer in clinical governance.
Mel says that working in clinical research gives her an opportunity to interact with people and help make a real difference to people’s lives.
We are honored to have Dr Lay Gan join the Genesis investigator team. Dr Gan is a clinical gastroenterologist who practices in general gastroenterology and hepatology. She has a keen interest in all forms of liver disease and extensive experience in the management of inflammatory bowel disease.
Dr Gan is a principal investigator for several clinical trials in metabolic fatty liver and inflammatory bowel diseases. She also holds a PhD from the Australian National University in Canberra, with her thesis on Mechanistic Studies of Cholesterol Lipotoxicity Pertinent to NASH.
She takes pride in her holistic patient-centered care, ensuring patients are actively involved in their treatment and decision-making.
Kudos to the study team for achieving the highest participant recruitment in a clinical trial involving a new medical device. The study is evaluating an investigational spinal cord stimulator indicated for people living with chronic back and/or leg pain.
We were the first site to have a participant undergo a trial of an investigational medical device for chronic migraine. This is a first-in-human clinical trial. The device is an implantable stimulator designed to reduce the frequency of migraines and severity of headache pain.
October is National Breast Cancer Awareness month. In support of the National Breast Cancer Foundation (NBCF), we organized a Pink Ribbon Breakfast on October 23rd. Our team dressed up in pink and brought delicious baked treats to share.
A heartfelt thank you to everyone that attended or donated online. With your collective support, we raised $589.90, which will contribute to cutting-edge breast cancer research!
November 6th was ‘Color the World Orange’ day – a day dedicated to raising awareness about CRPS (Complex Regional Pain Syndrome). CRPS is an extremely painful and disabling condition that can develop in a limb after an injury or trauma. It often causes great distress and reduced quality of life.
We asked the team to wear something orange and bring in some orange treats to share.
It has been a year since we launched our Research Fundamentals Training Course, which means it’s time to end our introductory price offer. The course is currently on offer for AUD180. This will increase to AUD230 on January 1st, 2024.
Thank you to everyone who chose to learn with us this year, and a special thank you to those who provided detailed feedback after completing the Research Fundamentals Training Course. We are always looking to improve our courses and truly appreciate your comments.
Did you know that we provide participant recruitment services to sponsors, hospitals, universities, and independent trial sites? We offer contemporary social media advertising campaigns, as well as print media and trial website development options tailored to your study.
We leverage the power of social media for demographic and geographic targeting, allowing participants to interact, learn more, and pre-qualify for studies. We track progress, adjust as needed, and report results back to you.
Our recruitment staff are trained in social media advertising and maintain ICH-GCP certification, ensuring efficient participant recruitment strategies that comply with ethical standards.
We were proud to see the 6-month results of our investigator-initiated clinical study published in the world-class journal, Neuromodulation.
In this study, we evaluated the safety and effectiveness of a new spinal cord stimulation (SCS) waveform designed to treat chronic neuropathic low back pain. Eligible study participants received an implanted SCS device and tried different stimulation programs over a 12-month study period. After 6 months, 77% of participants had their pain reduced by more than half, and almost 50% of participants had over 80% pain relief.
A huge thank you to our participants for taking part in this study.
We plan to have the 12-month results published next year.
View our currently recruiting studies:
Register your interest for future studies:
© Genesis Research Services, 2023